Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized TrialAntonio Palumbo, Mario Boccadoro|Journal of Clinical Oncology|2011Cited by 321
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted MyelomaMarco Ladetto, Antonio Palumbo, Vincenzo Callea et al.|Journal of Clinical Oncology|2010Cited by 268
Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survivalSimone Ferrero, Antonio Palumbo, Marco Ladetto et al.|Leukemia|2014Cited by 83
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapyFederica Cavallo, Antonio Palumbo, Giuseppe Milone et al.|Leukemia|2011Cited by 63
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesS Caltagirone, Paola Omedè, Marina Ruggeri et al.|Haematologica|2014Cited by 22